Abstract
In addition to the aging of gastric cancer patients in recent years, those with advanced gastric cancer often receive suboptimal nutritional care preoperatively, given the physical impact of gastric cancer-related nutritional intolerance and tumor-bearing status. Available records indicate that poor preoperative nutritional status, especially sarcopenia, may culminate in poor short-term postoperative outcomes and diminished long-term cancer prognosis. Furthermore, it is widely acknowledged that postoperative weight loss and the loss of muscle mass have an adverse effect on the prognosis. To tackle these issues, clinical trials have been conducted on perioperative nutritional interventions which have demonstrated a certain degree of effectiveness. This paper presents recent reports emphasizing the significance of nutritional management in the treatment of gastric cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
